Status:
UNKNOWN
High Flow Nasal Cannula in Immunocompromised Patient With Acute Respiratory Failure
Lead Sponsor:
Ain Shams University
Conditions:
High Flow Nasal Cannula
Non Invasive Ventilation
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
This study will be conducted in Ain Shams University Hospital in the general intensive care unit after ethical committee approval number (FMASU R 9/2020) .It is a prospective randomized controlled stu...
Detailed Description
ARF is characterized by respiratory rate more than 25/min, PaO2/FiO2 less than 300 under standard O2 10 L/min, or findings of persistent pulmonary infiltrates in radiographs. Immunocompromised patien...
Eligibility Criteria
Inclusion
- . Inclusion criteria includes admitted immunocompromised patient to ICU with acute hypoxemic respiratory failure (ARF).
- Hematological malignancies.
- Post bone marrow transplantation
Exclusion
- Need of emergency intubation.
- patient with deterioration of conscious level with hypoxemia with FiO2 less than 90% in spite of maximum O2 support.
- hemodynamic instability with need of vasoconstrictor support.
Key Trial Info
Start Date :
March 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2020
Estimated Enrollment :
76 Patients enrolled
Trial Details
Trial ID
NCT04293991
Start Date
March 1 2020
End Date
August 1 2020
Last Update
March 3 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.